{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:06:55Z","timestamp":1778897215033,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":133,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sleephealthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Health"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.sleh.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T11:18:06Z","timestamp":1753960686000},"page":"754-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A descriptive study of national trends in the dispensing of reimbursed hypnotics in France between 2012 and 2022"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2486-7448","authenticated-orcid":false,"given":"Lionel","family":"Tordjman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-632X","authenticated-orcid":false,"given":"Marc-Andr\u00e9","family":"Goltz\u00e8ne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-0985","authenticated-orcid":false,"given":"Elisabeth","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleh.2025.07.002_bib1","series-title":"The International Classification of Sleep Disorders, Diagnostic and Coding Manual","year":"2014"},{"issue":"1","key":"10.1016\/j.sleh.2025.07.002_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2869.2000.00178.x","article-title":"Prevalence of insomnia in a survey of 12,778 adults in France","volume":"9","author":"Leger","year":"2000","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleh.2025.07.002_bib3","unstructured":"L\u00e9ger D. Le temps de sommeil en France\/Sleep Time in France."},{"key":"10.1016\/j.sleh.2025.07.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101456","article-title":"The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: a systematic review and meta-analysis","volume":"59","author":"Johnson","year":"2021","journal-title":"Sleep Med Rev"},{"issue":"1","key":"10.1016\/j.sleh.2025.07.002_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2047487312460020","article-title":"Insomnia and risk of cardiovascular disease: a meta-analysis","volume":"21","author":"Sofi","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.sleh.2025.07.002_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.smrv.2018.10.006","article-title":"Insomnia as a predictor of mental disorders: a systematic review and meta-analysis","volume":"43","author":"Hertenstein","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"8","key":"10.1016\/j.sleh.2025.07.002_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleep\/zsy083","article-title":"The economic cost of inadequate sleep","volume":"41","author":"Hillman","year":"2018","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.sleh.2025.07.002_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.smrv.2008.06.001","article-title":"The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies","volume":"13","author":"Riemann","year":"2009","journal-title":"Sleep Med Rev"},{"issue":"6","key":"10.1016\/j.sleh.2025.07.002_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleh.2025.07.002_bib10","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet]. [cited 2024 September 16]. Prise en charge du patient adulte se plaignant d\u2019insomnie en m\u00e9decine g\u00e9n\u00e9rale. Available at: \u3008https:\/\/www.has-sante.fr\/jcms\/c_522637\/fr\/prise-en-charge-du-patient-adulte-se-plaignant-d-insomnie-en-medecine-generale\u3009."},{"issue":"1","key":"10.1016\/j.sleh.2025.07.002_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00228-018-2563-9","article-title":"Twelve-year trend in the use of zolpidem and physicians\u2019 non-compliance with recommended duration: a Korean national health insurance database study","volume":"75","author":"Jang","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.sleh.2025.07.002_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","article-title":"The clinical and forensic toxicology of Z-drugs","volume":"9","author":"Gunja","year":"2013","journal-title":"J Med Toxicol"},{"issue":"5","key":"10.1016\/j.sleh.2025.07.002_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European Union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Eur Addict Res"},{"issue":"1","key":"10.1016\/j.sleh.2025.07.002_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10550887.2014.882725","article-title":"An update on zolpidem abuse and dependence","volume":"33","author":"Victorri-Vigneau","year":"2014","journal-title":"J Addict Dis"},{"issue":"5","key":"10.1016\/j.sleh.2025.07.002_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2515\/therapie:2003069","article-title":"Impacts of the new flunitrazepam regulations on the consumption of hypnotics","volume":"58","author":"Victorri-Vigneau","year":"2003","journal-title":"Therapie"},{"issue":"2","key":"10.1016\/j.sleh.2025.07.002_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228495","article-title":"Prevalence of zolpidem use in France halved after secure prescription pads implementation in 2017: a SNDS database nested cohort study","volume":"15","author":"Caillet","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.sleh.2025.07.002_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027443","article-title":"French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol","volume":"9","author":"G\u00e9rardin","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.sleh.2025.07.002_bib18","unstructured":"ANSM \u2013 RAPPORT BENZODIAZEPINES [Internet]. Addictovigilance Paris. 2017 [cited 2024 September 16]. Available at: \u3008https:\/\/addictovigilance.aphp.fr\/2017\/05\/23\/ansm-rapport-benzodiazepines\/\u3009."},{"key":"10.1016\/j.sleh.2025.07.002_bib19","unstructured":"VIDAL [Internet]. [cited 2024 September 16]. Recommandations Insomnie de l\u2019adulte. Available at: \u3008https:\/\/www.vidal.fr\/maladies\/recommandations\/insomnie-de-l-adulte-1619.html\u3009."},{"key":"10.1016\/j.sleh.2025.07.002_bib20","unstructured":"VIDAL [Internet]. 2024 [cited 2024 June 6]. M\u00e9dicaments hypnotiques: baisse du taux de remboursement \u00e0 partir du 1er d\u00e9cembre 2014. Available at: \u3008https:\/\/www.vidal.fr\/actualites\/14442-medicaments-hypnotiques-baisse-du-taux-de-remboursement-a-partir-du-1er-decembre-2014.html\u3009."},{"key":"10.1016\/j.sleh.2025.07.002_bib21","unstructured":"VIDAL [Internet]. 2024 [cited 2024 June 6]. Insomnies: MOGADON (nitraz\u00e9pam) ne sera plus remboursable au 1er mars 2018. Available at: \u3008https:\/\/www.vidal.fr\/actualites\/22526-insomnies-mogadon-nitrazepam-ne-sera-plus-remboursable-au-1er-mars-2018.html\u3009."},{"key":"10.1016\/j.sleh.2025.07.002_bib22","unstructured":"Prescription obligatoire du zolpidem sur ordonnance s\u00e9curis\u00e9e - Point d\u2019Information - ANSM: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 [Internet]. 2024 [cited 2024 June 6]. Available at: \u3008https:\/\/archive.ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Prescription-obligatoire-du-zolpidem-sur-ordonnance-securisee-Point-d-Information\u3009."},{"key":"10.1016\/j.sleh.2025.07.002_bib23","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet]. 2024 [cited 2024 June 9]. QUVIVIQ (daridorexant) - Insomnie chronique. Available at: \u3008https:\/\/www.has-sante.fr\/jcms\/p_3443615\/fr\/quviviq-daridorexant-insomnie-chronique\u3009."},{"key":"10.1016\/j.sleh.2025.07.002_bib24","unstructured":"M\u00e9dicaments d\u00e9livr\u00e9s par les pharmacies de ville par type de prescripteur - Medic\u2019AM - 2015 \u00e0 2024 | L\u2019Assurance Maladie [Internet]. 2024 [cited 2024 September 5]. Available at: \u3008https:\/\/www.assurance-maladie.ameli.fr\/etudes-et-donnees\/medicaments-type-prescripteur-medicam\u3009."},{"key":"10.1016\/j.sleh.2025.07.002_bib25","unstructured":"Donn\u00e9esMondiales.com [Internet]. [cited 2025 April 6]. Croissance de la population en France. Available at: \u3008https:\/\/www.donneesmondiales.com\/europe\/france\/croissance-population.php\u3009."},{"issue":"1","key":"10.1016\/j.sleh.2025.07.002_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13119","article-title":"Covid-19 health crisis and lockdown associated with high level of sleep complaints and hypnotic uptake at the population level","volume":"30","author":"Beck","year":"2021","journal-title":"J Sleep Res"},{"issue":"8","key":"10.1016\/j.sleh.2025.07.002_bib27","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1111\/bcp.14753","article-title":"Change in the regulatory framework for zolpidem: what is the impact on the landscape of the prescription of sedative medications? The French national ZORRO study","volume":"87","author":"Istvan","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sleh.2025.07.002_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-019-02737-7","article-title":"Consequences of the new zolpidem prescription regulations: a cohort study from the French national healthcare database","volume":"76","author":"Touchard","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.sleh.2025.07.002_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jagp.2018.10.017","article-title":"Trends in insomnia diagnosis and treatment among medicare beneficiaries, 2006-2013","volume":"27","author":"Albrecht","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.sleh.2025.07.002_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/appi.ps.201700095","article-title":"Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999-2014","volume":"69","author":"Kaufmann","year":"2018","journal-title":"Psychiatr Serv"},{"issue":"21","key":"10.1016\/j.sleh.2025.07.002_bib31","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.2020.19224","article-title":"Trends in dispensing of zolpidem and low-dose trazodone among commercially insured adults in the United States, 2011-2018","volume":"324","author":"Wong","year":"2020","journal-title":"JAMA"},{"issue":"712","key":"10.1016\/j.sleh.2025.07.002_bib32","doi-asserted-by":"crossref","first-page":"e877","DOI":"10.3399\/BJGP.2021.0054","article-title":"Trends in the prescription of drugs used for insomnia: an open-cohort study in Australian general practice, 2011-2018","volume":"71","author":"Begum","year":"2021","journal-title":"Br J Gen Pract"},{"issue":"1","key":"10.1016\/j.sleh.2025.07.002_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12888-023-04683-2","article-title":"Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database","volume":"23","author":"Okuda","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.sleh.2025.07.002_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.915823","article-title":"Trends in prescriptions for insomnia in a province in China between 2015 and 2019","volume":"13","author":"Lou","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.sleh.2025.07.002_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.sleep.2025.01.004","article-title":"Trends in anti-insomnia medication utilization among pediatric patients in nine cities in China: a real-world study (2016-2023)","volume":"127","author":"Li","year":"2025","journal-title":"Sleep Med"}],"container-title":["Sleep Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352721825001408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352721825001408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:07:35Z","timestamp":1778893655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352721825001408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2352721825001408"],"URL":"https:\/\/doi.org\/10.1016\/j.sleh.2025.07.002","relation":{},"ISSN":["2352-7218"],"issn-type":[{"value":"2352-7218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A descriptive study of national trends in the dispensing of reimbursed hypnotics in France between 2012 and 2022","name":"articletitle","label":"Article Title"},{"value":"Sleep Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleh.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Sleep Foundation.","name":"copyright","label":"Copyright"}]}}